Quest Diagnostics Income Statement
DGX / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Quest Diagnostics reported $11.0B in revenue and $992M in net income for FY2025. Revenue has grown at a 2.9% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.0B | $9.9B | $10.8B | $9.4B | $7.7B | $9.4B | $7.4B | $7.2B | $7.5B | $7.4B | $7.1B | $7.4B | $7.4B | $7.4B | $7.4B |
| Cost of Revenue | $7.4B | $6.6B | $6.6B | $5.8B | $5.0B | $5.8B | $4.7B | $4.6B | $4.7B | $4.6B | $4.3B | $4.6B | $4.4B | $4.4B | $4.4B |
| Gross Profit | - | - | - | - | - | $3.6B | $2.6B | $2.7B | $2.9B | $2.8B | $2.8B | $2.8B | $3.0B | $3.0B | $3.0B |
| SG&A Expense | $2.0B | $1.8B | $1.7B | $1.6B | $1.5B | $1.6B | $1.4B | $1.4B | $1.7B | $1.7B | $1.7B | $1.7B | $1.7B | $1.7B | $1.7B |
| Operating Income | $1.6B | $1.3B | $2.4B | $2.0B | $1.2B | $2.0B | $1.2B | $1.3B | $1.4B | $983.0M | $1.5B | $983.0M | $987.0M | $1.2B | $987.0M |
| Interest Expense | - | - | $152.0M | $166.0M | $180.0M | $166.0M | $153.0M | $144.0M | $154.0M | $167.0M | -$159.0M | $167.0M | - | - | $173.3M |
| Income Tax | $314.0M | $273.0M | $597.0M | $460.0M | $247.0M | $460.0M | $241.0M | $429.0M | $373.0M | $262.0M | $500.0M | $262.0M | $355.0M | $402.0M | $355.0M |
| Net Income | $992.0M | $871.0M | $2.0B | $1.4B | $858.0M | $1.4B | $772.0M | $645.0M | $709.0M | $556.0M | $849.0M | $556.0M | $471.0M | $556.0M | $471.0M |
| EPS (Basic) | $7.59 | $8.10 | $15.85 | $10.62 | $6.36 | $5.39 | $5.63 | $4.58 | $4.92 | $3.83 | $5.58 | $3.49 | $2.95 | $4.08 | $3.91 |
| EPS (Diluted) | $7.49 | $7.97 | $15.55 | $10.47 | $6.28 | $5.29 | $5.50 | $4.51 | $4.87 | $3.81 | $5.54 | $3.46 | $2.92 | $4.05 | $3.87 |
| Shares Outstanding | 113.0M | 118.0M | 128.0M | 136.0M | 136.0M | 139.0M | 140.0M | 142.0M | 145.0M | 145.0M | 153.0M | 160.0M | 160.0M | 177.3M | 187.8M |
| Gross Margin | - | - | - | - | - | 38.5% | 35.2% | 37.2% | 38.7% | 38.1% | 39.1% | 37.6% | 40.8% | 40.9% | 41.0% |
| Operating Margin | 14.1% | 13.6% | 22.1% | 20.9% | 15.9% | 20.9% | 15.7% | 17.7% | 18.7% | 13.2% | 20.6% | 13.2% | 13.4% | 16.3% | 13.4% |
| Profit Margin | 9.0% | 8.8% | 18.5% | 15.2% | 11.1% | 15.2% | 10.4% | 8.9% | 9.5% | 7.5% | 11.9% | 7.5% | 6.4% | 7.5% | 6.4% |